ALN-TTR01

· Alnylam Pharmaceuticals

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ALN-TTR01, covering 2012-05-24 to 2012-05-24. Get the full timeline:

Most recent: Clinical Trial Update: Trial to Evaluate Safety and Tolerability of ALN-TTR01 in Transthyretin (TTR) Amyloidosis [Phase 1]